Required to reconstitute lyophilized peptides before use in research.
Key findings from published peer-reviewed research studies.
Disclaimer: This product is intended for research use only. Not for human consumption, therapeutic use, or diagnostic purposes.
| Chemical Name | Tirzepatide |
| CAS Number | 2023788-19-2 |
| Molecular Formula | C₂₂₅H₃₄₈N₄₈O₆₈ |
| Molecular Weight | 4,813.45 g/mol |
| Peptide Length | 39 amino acids |
| Mechanism | Dual GIP/GLP-1 receptor agonist |
| Appearance | White to off-white lyophilized powder |
| Solubility | Soluble in sterile water, bacteriostatic water |
| Purity | ≥99% (HPLC) |
| Endotoxin Level | <0.1 EU/mg |
Tirzepatide is a first-in-class dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It was developed for metabolic research and has shown unprecedented efficacy in clinical trials.
Unlike GLP-1-only agonists (e.g., semaglutide), tirzepatide activates both GIP and GLP-1 receptors. This dual mechanism provides additive effects on insulin secretion, glucose control, and weight management in research models.
SURPASS is a series of Phase 3 clinical trials evaluating tirzepatide for type 2 diabetes. SURMOUNT trials investigate its use in obesity research. Both programs have demonstrated best-in-class efficacy.
Store lyophilized tirzepatide at -20°C for long-term storage. Reconstituted solution should be stored at 2-8°C and used within 14 days.
Each batch undergoes HPLC purity analysis, mass spectrometry for identity, endotoxin testing, sterility testing, and residual solvent analysis to ensure pharmaceutical-grade quality.
Peer-reviewed publications and reference materials.
Our products are strictly intended for laboratory research use only. Not for human or animal consumption. By purchasing, you confirm that you are a licensed researcher or purchasing for research purposes.
